BAC
Bank of America Corporation
BAC has slightly lower modeled downside risk, despite its lower overall score.
EG
Everest Re Group, Ltd.
EG has the edge over BAC overall, supported by stronger valuation.
BAC Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Strong | |
| N/A | |
| N/A |
BAC's revenue and profitability are currently healthy. Free cash flow and net leverage aren't meaningful measures for financial services companies like BAC.
EG Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Strong | |
| N/A | |
| N/A |
EG's profitability is currently strong, but its revenue is under pressure. Free cash flow and net leverage aren't meaningful measures for financial services companies like EG.
BAC PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 9.4x | $39.50 | -22% |
| Forward | 10x | $50.51 | — |
| Current | 12x | $50.51 | — |
| Fair | 13x | $53.81 | +6.5% |
| Expensive | 15x | $62.23 | +23% |
Historical ranges are pointers, not guarantees.
BAC's PE is in its fair range at 12x. If earnings grow as analysts expect, today's price would be 10x next year's earnings, in its cheap range.
EG PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 6.9x | $325 | -23% |
| Forward | 7.3x | $422 | — |
| Current | 8.9x | $422 | — |
| Fair | 11x | $543 | +29% |
| Expensive | 21x | $982 | +133% |
Historical ranges are pointers, not guarantees.
EG has the edge over BAC in the historical PE scenario, which offers more potential upside but is not a forecast.
BAC Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
BAC has the edge over EG on the outlook, with more favorable revenue expectations.
EG Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Decline | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect EG's earnings to grow and its profitability to improve, but its revenue to decline.
BAC Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $4.92 | +17% |
| Q3 2026 | $4.19 | +14% |
| Q2 2026 | $4.34 | +27% |
| Q1 2026 | $4.02 | +20% |
| Q4 2025 | $3.81 | +19% |
| Q3 2025 | $3.66 | +33% |
| Q2 2025 | $3.41 | +20% |
| Q1 2025 | $3.35 | +16% |
| Q4 2024 | $3.21 | +4.2% |
BAC has the edge over EG on earnings, with more consistent year-over-year improvement.
EG Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $58.04 | +23% |
| Q3 2026 | $47.26 | +250% |
| Q2 2026 | $47.23 | +146% |
| Q1 2026 | $49.11 | +148% |
| Q4 2025 | $37.80 | +19% |
| Q3 2025 | $13.50 | -79% |
| Q2 2025 | $19.21 | -72% |
| Q1 2025 | $19.81 | -71% |
| Q4 2024 | $31.78 | -47% |
EG's earnings per share have fallen from their peak: $47.26 over the past year, against $68.19 in mid-2024.
BAC Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $30B | +6.7% |
| Q2 2026 | $31.6B | +19% |
| Q1 2026 | $30.3B | +11% |
| Q4 2025 | $31.2B | +23% |
| Q3 2025 | $28.1B | +11% |
| Q2 2025 | $26.5B | +4.3% |
| Q1 2025 | $27.4B | +6% |
| Q4 2024 | $25.3B | +15% |
BAC has the edge over EG on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 30% | -3.7 points |
| Q2 2026 | 37% | +7.6 points |
| Q1 2026 | 34% | +4.7 points |
| Q4 2025 | 40% | +12 points |
| Q3 2025 | 34% | +4.8 points |
| Q2 2025 | 29% | -0.7 points |
| Q1 2025 | 30% | +1.5 points |
| Q4 2024 | 28% | +14 points |
BAC has the edge over EG on profitability, with a higher operating margin.
EG Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | -14% |
| Q2 2026 | $4B | -12% |
| Q1 2026 | $4.1B | -4.6% |
| Q4 2025 | $4.4B | -4.6% |
| Q3 2025 | $4.3B | +0.8% |
| Q2 2025 | $4.5B | +6.2% |
| Q1 2025 | $4.3B | +3.1% |
| Q4 2024 | $4.6B | +27% |
EG's revenue has slid since its 2024 peak: $3.7B last quarter, down 14% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7.2% | +1 points |
| Q2 2026 | 17% | -0.9 points |
| Q1 2026 | 18% | +12 points |
| Q4 2025 | 13% | +29 points |
| Q3 2025 | 6.2% | -7.2 points |
| Q2 2025 | 18% | -1.5 points |
| Q1 2025 | 5.8% | -14 points |
| Q4 2024 | -16% | -24 points |
EG's operating margin was 7.2% last quarter, up 1 points from the same quarter a year ago.
BAC Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$6.5B | -114% |
| Q2 2026 | $29B | +$38.2B |
| Q1 2026 | $41.8B | +$44B |
| Q4 2025 | -$22.9B | -189% |
| Q3 2025 | $46.9B | +$84.2B |
| Q2 2025 | -$9.1B | -150% |
| Q1 2025 | -$2.2B | +$13.4B |
| Q4 2024 | $25.9B | -21% |
BAC has the edge over EG on cash flow, with more consistent year-over-year improvement.
EG Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $667M | -54% |
| Q2 2026 | $290M | -73% |
| Q1 2026 | $649M | -30% |
| Q4 2025 | -$398M | -151% |
| Q3 2025 | $1.5B | -16% |
| Q2 2025 | $1.1B | -19% |
| Q1 2025 | $928M | -16% |
| Q4 2024 | $780M | -23% |
EG's free cash flow was $1.2B over the past year, down 72% from the year before. Free cash flow isn't a meaningful measure for financial services companies like EG.
BAC Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -1% | -72M shares |
| 1 year | -5.3% | -405M shares |
| 3 years | -11% | -854M shares |
| 5 years | -15% | -1.3B shares |
| Available history | -24% | -2.2B shares |
BAC has 7.2B diluted shares, down 5.3% from a year ago, with $25.6B in buybacks over the past year.
| Quarter | Spent |
|---|---|
| Q3 2026 | $6B |
| Q2 2026 | $6B |
| Q1 2026 | $7.2B |
| Q4 2025 | $6.3B |
| Q3 2025 | $5.3B |
| Q2 2025 | $5.3B |
| Q1 2025 | $4.5B |
| Q4 2024 | $3.5B |
BAC spent $25.6B buying back its own shares over the past year, up 37% from the year before.
EG Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -3.1% | -1.2M shares |
| 1 year | -9.2% | -3.8M shares |
| 3 years | -12% | -5.3M shares |
| 5 years | -5% | -2M shares |
| Available history | -6.7% | -2.7M shares |
EG has the edge over BAC on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | $473M |
| Q2 2026 | $395M |
| Q1 2026 | $330M |
| Q4 2025 | $397M |
| Q3 2025 | — |
| Q2 2025 | $200M |
| Q1 2025 | $200M |
| Q4 2024 | — |
EG spent $1.6B buying back its own shares over the past year, about four times what it spent the year before.
BAC Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 6.4x | High |
| Q2 2026 | 6.7x | High |
| Q1 2026 | 7.1x | High |
| Q4 2025 | 7.7x | High |
| Q3 2025 | 8.3x | High |
| Q2 2025 | 8.8x | High |
| Q1 2025 | 8.6x | High |
| Q4 2024 | 9.0x | High |
BAC's net debt is about 6.4 years of its operating earnings (EBITDA), down from 8.3 years a year ago. Net leverage isn't a meaningful measure for financial services companies like BAC.
EG Net Leverage
BAC Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 37.1 | Neutral |
| Stochastic | 4.9 | Oversold |
BAC's weekly RSI is 37 (neutral) and its Stochastic is 5 (oversold).
EG Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 74.6 | Overbought |
| Stochastic | 85.0 | Overbought |
EG's weekly RSI is 75 (overbought) and its Stochastic is 85 (overbought).
BAC PE vs Financial Services Sector
| Metric | BAC | Sector median | Relative |
|---|---|---|---|
| PE | 12x | 13x | 7.5% below |
| PE % | 40 | 63 | 23 pts below |
BAC is trading at 12x earnings, in line with the Financial Services sector's median of 13x.
EG PE vs Financial Services Sector
| Metric | EG | Sector median | Relative |
|---|---|---|---|
| PE | 8.9x | 13x | 31% below |
| PE % | 41 | 63 | 22 pts below |
EG has the edge over BAC on valuation relative to its sector.
BAC Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $52.1 | 3% below |
| 20 week MA | $57.8 | 13% below |
| 50 week MA | $54.7 | 7.7% below |
| 100 week MA | $50.5 | 0% below |
| 200 week MA | $42.5 | 19% above |
BAC has fallen below most of its moving averages, though it's still 19% above its 200-week average.
EG Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $392.4 | 7.6% above |
| 20 week MA | $382.2 | 11% above |
| 50 week MA | $353.5 | 19% above |
| 100 week MA | $348.5 | 21% above |
| 200 week MA | $360.6 | 17% above |
EG has the edge over BAC on trend strength, trading above more of its moving averages.
BAC Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $35.4 | $30.0 | -15% |
| 2021 | $30.0 | $44.4 | +48% |
| 2022 | $44.4 | $32.5 | -27% |
| 2023 | $32.5 | $33.7 | +3.7% |
| 2024 | $33.7 | $44.3 | +32% |
| 2025 | $44.3 | $56.2 | +27% |
| 2026 YTD | $56.2 | $50.5 | -10% |
BAC has finished higher in four of the last six years. It's down 10% so far in 2026.
EG Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $276.0 | $229.2 | -17% |
| 2021 | $229.2 | $267.0 | +17% |
| 2022 | $267.0 | $334.9 | +25% |
| 2023 | $334.9 | $353.6 | +5.6% |
| 2024 | $353.6 | $360.0 | +1.8% |
| 2025 | $360.0 | $337.5 | -6.2% |
| 2026 YTD | $337.5 | $422.3 | +25% |
EG has the edge over BAC on returns for 2026, with the stronger performance.